1100 IL-15 enhances cytotoxicity of sipuleucel-T from metastatic castration-resistant prostate cancer patients by activating CD8+ T and NK effector cells
1100 IL-15 enhances cytotoxicity of sipuleucel-T from metastatic castration-resistant prostate cancer patients by activating CD8+ T and NK effector cells